Skip to navigation Skip to content
  • Woodruff
  • Business
  • Health Sciences
  • Law
  • Rose
  • Oxford College
  • Theology
  • Schools
    • Undergraduate

      • Emory College
      • Oxford College
      • Business School
      • School of Nursing

      Community

      • Emory College
      • Oxford College
      • Business School
      • School of Nursing
    • Graduate

      • Business School
      • Graduate School
      • School of Law
      • School of Medicine
      • School of Nursing
      • School of Public Health
      • School of Theology
  • Libraries
    • Libraries

      • Robert W. Woodruff
      • Business
      • Chemistry
      • Health Sciences
      • Law
      • MARBL
      • Music & Media
      • Oxford College
      • Theology
    • Library Tools

      • Course Reserves
      • Databases
      • Digital Scholarship (ECDS)
      • discoverE
      • eJournals
      • Electronic Dissertations
      • EmoryFindingAids
      • EUCLID
      • ILLiad
      • OpenEmory
      • Research Guides
  • Resources
    • Resources

      • Administrative Offices
      • Emory Healthcare
      • Academic Calendars
      • Bookstore
      • Campus Maps
      • Shuttles and Parking
      • Athletics: Emory Eagles
      • Arts at Emory
      • Michael C. Carlos Museum
      • Emory News Center
      • Emory Report
    • Resources

      • Emergency Contacts
      • Information Technology (IT)
      • Outlook Web Access
      • Office 365
      • Blackboard
      • OPUS
      • PeopleSoft Financials: Compass
      • Careers
      • Human Resources
      • Emory Alumni Association
  • Browse
    • Works by Author
    • Works by Journal
    • Works by Subject
  • For Authors
    • How to Submit
    • Deposit Advice
    • Deposit Instructions
    • Author Rights
    • FAQ
    • Emory Open Access Policy
    • Open Access Fund
  • About OpenEmory
    • About OpenEmory
    • About Us
    • Citing Articles
    • Contact Us
    • Privacy Policy
    • Terms of Use
 
Contact Us

Filter Results:

Year

  • 2020 (11)
  • 2019 (8)
  • 2018 (6)
  • 2016 (4)
  • 2021 (4)
  • 2011 (2)
  • 2012 (2)
  • 2014 (2)
  • 2017 (2)
  • 2022 (2)
  • 2023 (2)
  • 2002 (1)
  • 2006 (1)
  • 2010 (1)
  • 2013 (1)

Author

  • Lim, Sung (4)
  • Ye, Keqiang (4)
  • Andreou, Pantelis (3)
  • Aranow, Cynthia (3)
  • Askanase, Anca (3)
  • Bae, Sang-Cheol (3)
  • Bernatsky, Sasha (3)
  • Gordon, Caroline (3)
  • Inanc, Murat (3)
  • Jacobsen, Soren (3)
  • Jonsen, Andreas (3)
  • Kirkland, Susan (3)
  • Legge, Alexandra (3)
  • Mackay, Meggan (3)
  • Manzi, Susan (3)
  • Nived, Ola (3)
  • Petri, Michelle (3)
  • Rahman, Anisur (3)
  • Ramos-Casals, Manuel (3)
  • Ramsey-Goldman, Rosalind (3)
  • Rockwood, Kenneth (3)
  • Romero-Diaz, Juanita (3)
  • Sanchez-Guerrero, Jorge (3)
  • Alarcon, Graciela S. (2)
  • Bruce, Ian N. (2)
  • Chen, Guangping (2)
  • Clarke, Ann E. (2)
  • Dooley, MA (2)
  • Factor, Stewart (2)
  • Ferdous, Salma (2)
  • Fortin, Paul (2)
  • Ginzler, Ellen M. (2)
  • Gooch, Jennifer (2)
  • Hanly, John G. (2)
  • Huang, Jing (2)
  • Kalunian, Kenneth C. (2)
  • Kamen, Diane L. (2)
  • Kang, Seong (2)
  • Khamashta, Munther A. (2)
  • Li, Chaoran (2)
  • Mao, Hui (2)
  • Merrill, Joan T. (2)
  • Nickerson, John (2)
  • Peschken, Christine A. (2)
  • Qian, Wei (2)
  • Ruiz-Irastorza, Guillermo (2)
  • Sands, Jeff (2)
  • Sivasami, Pulavendran (2)
  • Steinsson, Kristjan (2)
  • Urowitz, Murray B. (2)
  • Wallace, Daniel J. (2)
  • Wu, Hui (2)
  • Wu, Wenfei (2)
  • Yang, Lily (2)
  • Zoma, Asad A. (2)
  • van Vollenhoven, Ronald F. (2)
  • Aarsvold, John (1)
  • Adamson, David (1)
  • Aghokeng, Avelin (1)
  • Ahn, EH (1)
  • Al-Shaana, Rawaa (1)
  • Alarcon, GS (1)
  • Alarcon, Graciela S (1)
  • Amanso, Angelica Mastandrea (1)
  • Anderson, SE (1)
  • Andrade Forero, Liliana (1)
  • Andreou, P (1)
  • Ankala, Arunkanth (1)
  • Aranow, C (1)
  • Araya, Paula (1)
  • Ard, KL (1)
  • Arnold, Rebecca (1)
  • Arteel, Gavin E. (1)
  • Askanase, A (1)
  • Aturinda, I (1)
  • Avila Rios, Santiago (1)
  • Bae, S-C (1)
  • Bai, Renren (1)
  • Banach, Maciej (1)
  • Banerjee, Ayan (1)
  • Banerjee, Yajnavalka (1)
  • Baumann, Frank (1)
  • Belardinelli, Luiz (1)
  • Benoist, Christophe (1)
  • Bergmann, Carina (1)
  • Bernatsky, S (1)
  • Bertagnolio, Silvia (1)
  • Beschorner, Natalie (1)
  • Beteta, Enrique (1)
  • Bhatia, Kailash (1)
  • Bhatia, Shagun (1)
  • Bhudhikanok, Grace S (1)
  • Boatright, Jeffrey (1)
  • Boelmans, Kai (1)
  • Botchwey, Edward (1)
  • Bressman, Susan (1)
  • Bridges, Susan M. (1)
  • Brijkumar, J (1)
  • Bruce, IN (1)
  • Bruce, Ian N (1)

Subject

  • Health Sciences, Medicine and Surgery (14)
  • Biology, Cell (6)
  • Biology, Neuroscience (6)
  • Health Sciences, Immunology (6)
  • Health Sciences, Pathology (6)
  • Health Sciences, Radiology (6)
  • Chemistry, Biochemistry (5)
  • Health Sciences, General (5)
  • Health Sciences, Oncology (5)
  • Health Sciences, Pharmacology (5)
  • Biology, Genetics (4)
  • Engineering, Biomedical (4)
  • Health Sciences, Epidemiology (4)
  • Biology, Molecular (3)
  • Health Sciences, Nutrition (3)
  • Health Sciences, Opthamology (3)
  • Health Sciences, Public Health (3)
  • Biology, Microbiology (2)
  • Gerontology (2)
  • Agriculture, Plant Pathology (1)
  • Biology, Physiology (1)
  • Biology, Radiation (1)
  • Biology, Virology (1)
  • Biology, Zoology (1)
  • Chemistry, Pharmaceutical (1)
  • Environmental Sciences (1)
  • Health Sciences, Dentistry (1)
  • Physics, Radiation (1)
  • Psychology, Physiological (1)
  • Sociology, Ethnic and Racial Studies (1)

Journal

  • Journal of Neuroscience Nursing (2)
  • ARTHRITIS & RHEUMATOLOGY (1)
  • ARTHRITIS CARE & RESEARCH (1)
  • Aging Cell (1)
  • American Journal of Cardiology (1)
  • Analytical Cellular Pathology / Cellular Oncology (1)
  • Annals of Neurology (1)
  • Arteriosclerosis, Thrombosis, and Vascular Biology (1)
  • Arthritis & Rheumatology (1)
  • BMC Bioinformatics (1)
  • Blood Advances (1)
  • Burns (1)
  • CANCERS (1)
  • CELL METABOLISM (1)
  • CELLS (1)
  • COMMUNICATIONS BIOLOGY (1)
  • CURRENT OPINION IN IMMUNOLOGY (1)
  • Cell Reports (1)
  • ENVIRONMENTAL RESEARCH (1)
  • European Journal of Medicinal Chemistry (1)
  • FOOD CHEMISTRY (1)
  • Frontiers in Immunology (1)
  • Frontiers in Molecular Neurosciencee (1)
  • HIV MEDICINE (1)
  • Human Brain Mapping (1)
  • INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (1)
  • International Journal of Computer Assisted Radiology and Surgery (1)
  • International Journal of Nanomedicine (1)
  • JOURNAL OF BIOLOGICAL CHEMISTRY (1)
  • JOURNAL OF RHEUMATOLOGY (1)
  • Journal of Biological Chemistry (1)
  • Journal of Biological Chemistry (1)
  • Journal of Cellular and Molecular Medicine (1)
  • Journal of Pediatric Gastroenterology and Nutrition (1)
  • Journals of Gerontology, Series A (1)
  • LANCET INFECTIOUS DISEASES (1)
  • METABOLITES (1)
  • Molecular Vision (1)
  • Movement Disorders (1)
  • NATURE NEUROSCIENCE (1)
  • NATURE STRUCTURAL & MOLECULAR BIOLOGY (1)
  • NPJ PARKINSONS DISEASE (1)
  • OncoTargets and Therapy (1)
  • PHYSICS IN MEDICINE AND BIOLOGY (1)
  • Pflügers Archiv European Journal of Physiology (1)
  • SCIENCE OF THE TOTAL ENVIRONMENT (1)
  • Science Translational Medicine (1)
  • Theranostics (1)

Keyword

  • biomedicin (49)
  • scienc (49)
  • technolog (49)
  • cell (16)
  • biolog (15)
  • diseas (13)
  • activ (12)
  • molecular (10)
  • biochemistri (8)
  • medicin (8)
  • neurolog (8)
  • neurosci (8)
  • 1 (7)
  • express (7)
  • model (7)
  • risk (7)
  • a (6)
  • brain (6)
  • factor (6)
  • imag (6)
  • inhibit (6)
  • oxid (6)
  • 4 (5)
  • beta (5)
  • cardiovascular (5)
  • injuri (5)
  • mortal (5)
  • mous (5)
  • peopl (5)
  • protein (5)
  • resist (5)
  • system (5)
  • adult (4)
  • c (4)
  • damag (4)
  • deficit (4)
  • degener (4)
  • function (4)
  • gene (4)
  • index (4)
  • insulin (4)
  • iron (4)
  • local (4)
  • mice (4)
  • muscl (4)
  • pathogenesi (4)
  • phosphoryl (4)
  • popul (4)
  • research (4)
  • rheumatolog (4)
  • stress (4)
  • tissu (4)
  • transport (4)
  • 2 (3)
  • analysi (3)
  • appli (3)
  • associ (3)
  • cardiac (3)
  • clinic (3)
  • drug (3)
  • dysfunct (3)
  • environment (3)
  • experiment (3)
  • failur (3)
  • fat (3)
  • fit (3)
  • growth (3)
  • high (3)
  • in (3)
  • inflamm (3)
  • inhibitor (3)
  • insulinresist (3)
  • lipid (3)
  • mechan (3)
  • medic (3)
  • membran (3)
  • mri (3)
  • nuclear (3)
  • obes (3)
  • outcom (3)
  • oxidas (3)
  • radiolog (3)
  • receptor (3)
  • registr (3)
  • relat (3)
  • renal (3)
  • riskfactor (3)
  • rna (3)
  • skelet (3)
  • surgeri (3)
  • t (3)
  • therapi (3)
  • urea (3)
  • ut (3)
  • 3 (2)
  • accuraci (2)
  • adipos (2)
  • africa (2)

Author affiliation

  • Position object (6) (2)
  • Department of Medicine, Karolinska Institutet. (1)
  • Position object (168) (1)
  • Position object (169) (1)

Author department

  • Pathology: Admin (5)
  • Medicine: Nephrology (4)
  • Medicine: Rheumatology (4)
  • Rad Onc: Admin (4)
  • Hum Gen: Admin (3)
  • Medicine: Cardiology (3)
  • Micro/Immun: Admin (3)
  • Neurology: Movement Disor (3)
  • Ophthal: Admin (3)
  • Physiology: Admin (3)
  • BME: Admin (2)
  • Medicine: Infectious Dis (2)
  • Rad: MR Research Lab (2)
  • Surgery: Oncology (2)
  • Biochem: Admin (1)
  • Biostatistics (1)
  • Chemistry (1)
  • Emerg Med: Admin (1)
  • Emory Temporary Services (1)
  • English (1)
  • Environmental Health (1)
  • Gastroenterology (1)
  • HMO: Med Onc (1)
  • IACUC (1)
  • Leukemia Lymphoma (1)
  • Medicine: Admin (1)
  • Medicine: Endocrinology (1)
  • Medicine: Immunology (1)
  • Medicine: Pulmonary (1)
  • Neurology: Cog Neurobehav (1)
  • Neurology: Neuromuscular (1)
  • Neurosurgery: Admin (1)
  • Ofc Research Fund Supprt (1)
  • Orthopaedics: Admin (1)
  • Pharmacology: Admin (1)
  • Rad: Admin (1)
  • Rad: Rsch Labs - Gen (1)
  • Urology: Admin (1)

Search Results for all work with filters:

  • accumul
  • life

Work 1-10 of 49

Sorted by relevance
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
>

Article

Polymerase delta-Interacting Protein 2 Promotes Postischemic Neovascularization of the Mouse Hindlimb

by Angelica Mastandrea Amanso; Bernard Lassegue; Giji Joseph; Natalia Landazuri; James S. Long; Daiana Weiss; William Taylor; Kathy Griendling

2014

Subjects
  • Health Sciences, Medicine and Surgery
  • Engineering, Biomedical
  • File Download
  • View Abstract

Abstract:Close

OBJECTIVE - Collateral vessel formation can functionally compensate for obstructive vascular lesions in patients with atherosclerosis. Neovascularization processes are triggered by fluid shear stress, hypoxia, growth factors, chemokines, proteases, and inflammation, as well as reactive oxygen species, in response to ischemia. Polymerase δ-interacting protein 2 (Poldip2) is a multifunctional protein that regulates focal adhesion turnover and vascular smooth muscle cell migration and modifies extracellular matrix composition. We, therefore, tested the hypothesis that loss of Poldip2 impairs collateral formation. APPROACH AND RESULTS - The mouse hindlimb ischemia model has been used to understand mechanisms involved in postnatal blood vessel formation. Poldip2+/- mice were subjected to femoral artery excision, and functional and morphological analysis of blood vessel formation was performed after injury. Heterozygous deletion of Poldip2 decreased the blood flow recovery and spontaneous running activity at 21 days after injury. H 2O2 production, as well as the activity of matrix metalloproteinases-2 and -9, was reduced in these animals compared with Poldip2+/+ mice. Infiltration of macrophages in the peri-injury muscle was also decreased; however, macrophage phenotype was similar between genotypes. In addition, the formation of capillaries and arterioles was impaired, as was angiogenesis, in agreement with a decrease in proliferation observed in endothelial cells treated with small interfering RNA against Poldip2. Finally, regression of newly formed vessels and apoptosis was more pronounced in Poldip2+/- mice. CONCLUSIONS - Together, these results suggest that Poldip2 promotes ischemia-induced collateral vessel formation via multiple mechanisms that likely involve reactive oxygen species-dependent activation of matrix metalloproteinase activity, as well as enhanced vascular cell growth and survival.

Article

Mass Cytometry Reveals Global Immune Remodeling with Multi-lineage Hypersensitivity to Type I Interferon in Down Syndrome

by Katherine A Waugh; Paula Araya; Ahwan Pandey; Kimberly R Jordan; Keith P Smith; Ross E Granrath; Santosh Khanal; Eric T Butcher; Belinda E Estrada; Christopher Porter

2019

Subjects
  • Health Sciences, Pharmacology
  • Biology, Molecular
  • Health Sciences, Immunology
  • File Download
  • View Abstract

Abstract:Close

People with Down syndrome (DS; trisomy 21) display a different disease spectrum relative to the general population, including lower rates of solid malignancies and higher incidence of neurological and autoimmune conditions. However, the mechanisms driving this unique clinical profile await elucidation. We completed a deep mapping of the immune system in adults with DS using mass cytometry to evaluate 100 immune cell types, which revealed global immune dysregulation consistent with chronic inflammation, including key changes in the myeloid and lymphoid cell compartments. Furthermore, measurement of interferon-inducible phosphorylation events revealed widespread hypersensitivity to interferon-α in DS, with cell-type-specific variations in downstream intracellular signaling. Mechanistically, this could be explained by overexpression of the interferon receptors encoded on chromosome 21, as demonstrated by increased IFNAR1 surface expression in all immune lineages tested. These results point to interferon-driven immune dysregulation as a likely contributor to the developmental and clinical hallmarks of DS.

Article

Inhibition of IP6K1 suppresses neutrophil-mediated pulmonary damage in bacterial pneumonia

by Qingming Hou; Fei Liu; Anutosh Chakraborty; Yonghui Jia; Amit Prasad; Hongbo Yu; Li Zhao; Keqiang Ye; Solomon H. Snyder; Yuanfu Xu; Hongbo R. Luo

2018

Subjects
  • Biology, Cell
  • Health Sciences, Pathology
  • Health Sciences, Pharmacology
  • File Download
  • View Abstract

Abstract:Close

The significance of developing host-modulating personalized therapies to counteract the growing threat of antimicrobial resistance is well-recognized because such resistance cannot be overcome using microbe-centered strategies alone. Immune host defenses must be finely controlled during infection to balance pathogen clearance with unwanted inflammation-induced tissue damage. Thus, an ideal antimicrobial treatment would enhance bactericidal activity while preventing neutrophilic inflammation, which can induce tissue damage. We report that disrupting the inositol hexakisphosphate kinase 1 (Ip6k1) gene or pharmacologically inhibiting IP6K1 activity using the specific inhibitor TNP [N2-(m-(trifluoromethyl)benzyl) N6-(p-nitrobenzyl)purine] efficiently and effectively enhanced host bacterial killing but reduced pulmonary neutrophil accumulation, minimizing the lung damage caused by both Gram-positive and Gram-negative bacterial pneumonia. IP6K1-mediated inorganic polyphosphate (polyP) production by platelets was essential for infection-induced neutrophil-platelet aggregate (NPA) formation and facilitated neutrophil accumulation in alveolar spaces during bacterial pneumonia. IP6K1 inhibition reduced serum polyP levels, which regulated NPAs by triggering the bradykinin pathway and bradykinin-mediated neutrophil activation. Thus, we identified a mechanism that enhances host defenses while simultaneously suppressing neutrophil-mediated pulmonary damage in bacterial pneumonia. IP6K1 is, therefore, a legitimate therapeutic target for such disease.

Article

Platelet alpha-granules contribute to organ-specific pathologies in a mouse model of severe malaria

by Thayer K. Darling; Michael P. Schenk; Chengjing C. Zhou; Franklin M. Maloba; Patrice N. Mimche; Jonathan M. Gibbins; Shawn M. Jobe; Tracey Lamb

2020

Subjects
  • Health Sciences, Pathology
  • Health Sciences, Medicine and Surgery
  • File Download

Article

Probing and Enhancing Ligand-Mediated Active Targeting of Tumors Using Sub-5 nm Ultrafine Iron Oxide Nanoparticles

by Yaolin Xu; Hui Wu; Jing Huang; Wei Qian; Deborah E. Martinson; Bing Ji; Yuancheng Li; Yongqiang A. Wang; Lily Yang; Hui Mao

2020

Subjects
  • Health Sciences, Radiology
  • Biology, Cell
  • Health Sciences, Medicine and Surgery
  • Engineering, Biomedical
  • File Download
  • View Abstract

Abstract:Close

Rationale: “Active targeting” based on the ligand-target affinity is a common strategy to precisely deliver nanoparticle (NP) imaging probes or drug carriers to the diseased tissue. However, such ligand-mediated active targeting inevitably takes place with prerequisite “passive targeting”, driven by the enhanced permeability and retention (EPR) effect. Thus, the efficiency of active targeting in relation to off-targeted unbound NPs is of great importance in quantitative imaging of tumor biomarkers and delivery. With the notion that easy clearance of off-targeted uIONPs may lead to enhanced active targeting and tumor accumulation, we examined the NP size effect on “active targeting” of the transferrin receptor (TfR) using transferrin (Tf)-conjugated sub-5 nm (3 nm core) ultrafine iron oxide NPs (uIONPs) and larger IONPs (30 nm core). Methods: Green fluorescent dye (FITC)-labeled active targeting uIONPs (FITC-Tf-uIONPs) and red fluorescent dye (TRITC)-labeled passive targeting uIONPs (TRITC-uIONPs) were prepared. FITC-Tf-IONPs and TRITC-IONPs were used as comparison for the NP size effect. Multiphoton imaging, confocal fluorescence imaging, histological staining and computational analysis were applied to track different types of NPs in tumors at 1, 3 and 24 hours after co-injection of equal amounts of paired NPs, e.g., active targeting FITC-Tf-uIONPs and non-targeting TRITC-uIONPs, or FITC-Tf-IONPs and TRITC-IONPs into the same mice bearing 4T1 mouse mammary tumors. Results: Active targeting uIONPs exhibited an almost 6-fold higher level of tumor retention with deeper penetration comparing to non-targeting uIONPs at 24 hours after co-injection. However, accumulation of active targeting IONPs with a 30-nm core is only about 1.15-fold higher than non-targeting IONPs. The enhanced active targeting by uIONPs can be attributed to the size dependent clearance of unbound off-targeted NPs, as majority off-targeted uIONPs were readily cleared from the tumor by intravasation back into tumor blood vessels likely due to high interstitial pressure, even though they are not favorable for macrophage uptake. Conclusion: Ligand-mediated active targeting improves the delivery and accumulation of the sub-5 nm NPs. The improvement on active targeting is size-dependent and facilitated by NPs with sub-5 nm core sizes. Thus, sub-5 nm NPs may serve as favorable platforms for development of NP-based molecular imaging probes and targeted drug carriers.

Article

Head injury, alpha-synuclein Rep1, and Parkinson's disease

by Samuel M Goldman; Freya Kamel; G Webster Ross; Sarah A Jewell; Grace S Bhudhikanok; David Umbach; Connie Marras; Robert A Hauser; Joseph Jankovic; Stewart Factor; Susan Bressman; Kelly E Lyons; Cheryl Meng; Monica Korell; Diana F Roucoux; Jane A Hoppin; Dale P Sandler; J William Langston; Caroline M Tanner

2012

Subjects
  • Biology, Neuroscience
  • Biology, Genetics
  • File Download
  • View Abstract

Abstract:Close

Objective: To test the hypothesis that variability in SNCA Rep1, a polymorphic dinucleotide microsatellite in the promoter region of the gene encoding α-synuclein, modifies the association between head injury and Parkinson's disease (PD) risk. Methods: Participants in the Farming and Movement Evaluation (FAME) and the Study of Environmental Association and Risk of Parkinsonism using Case-Control Historical Interviews (SEARCH), 2 independent case-control studies, were genotyped for Rep1 and interviewed regarding head injuries with loss of consciousness or concussion prior to Parkinson's disease (PD) diagnosis. Logistic regression modeling adjusted for potential confounding variables and tested interaction between Rep1 genotype and head injury. Results: Consistent with prior reports, relative to medium-length Rep1, short Rep1 genotype was associated with reduced PD risk (pooled odds ratio [OR], 0.7; 95% confidence interval [CI], 0.5-0.9), and long Rep1 with increased risk (pooled OR, 1.4; 95% CI, 0.95-2.2). Overall, head injury was not significantly associated with PD (pooled OR, 1.3; 95% CI, 0.9-1.8). However, head injury was strongly associated with PD in those with long Rep1 (FAME OR, 5.4; 95% CI, 1.5-19; SEARCH OR, 2.3; 95% CI, 0.6-9.2; pooled OR, 3.5; 95% CI 1.4-9.2, p-interaction = 0.02). Individuals with both head injury and long Rep1 were diagnosed 4.9 years earlier than those with neither risk factor (p = 0.03). Interpretation: While head injury alone was not associated with PD risk, our data suggest head injury may initiate and/or accelerate neurodegeneration when levels of synuclein are high, as in those with Rep1 expansion. Given the high population frequency of head injury, independent verification of these results is essential.

Article

Modulation of kidney urea transporter UT-A3 activity by alpha2,6-sialylation

by Xiaoqian Qian; Jeff Sands; Xiang Song; Guangping Chen

2016

Subjects
  • Biology, Physiology
  • Biology, Cell
  • File Download
  • View Abstract

Abstract:Close

Two urea transporters, UT-A1 and UT-A3, are expressed in the kidney terminal inner medullary collecting duct (IMCD) and are important for the production of concentrated urine. UT-A1, as the largest isoform of all UT-A urea transporters, has gained much attention and been extensively studied; however, the role and the regulation of UT-A3 are less explored. In this study, we investigated UT-A3 regulation by glycosylation modification. A site-directed mutagenesis verified a single glycosylation site in UT-A3 at Asn279. Loss of the glycosylation reduced forskolin-stimulated UT-A3 cell membrane expression and urea transport activity. UT-A3 has two glycosylation forms, 45 and 65 kDa. Using sugar-specific binding lectins, the UT-A3 glycosylation profile was examined. The 45-kDa form was pulled down by lectin concanavalin A (Con A) and Galant husnivalis lectin (GNL), indicating an immature glycan with a high amount of mannose (Man), whereas the 65-kDa form is a mature glycan composed of acetylglucosamine (GlcNAc) and poly-N-acetyllactosame (poly-LacNAc) that was pulled down by wheat germ agglutinin (WGA) and tomato lectin, respectively. Interestingly, the mature form of UT-A3 glycan contains significant amounts of sialic acid. We explored the enzymes responsible for directing UT-A3 sialylation. Sialyltransferase ST6GalI, but not ST3GalIV, catabolizes UT-A3 α2,6-sialylation. Activation of protein kinase C (PKC) by PDB treatment promoted UT-A3 glycan sialylation and membrane surface expression. The PKC inhibitor chelerythrine blocks ST6GalI-induced UT-A3 sialylation. Increased sialylation by ST6GalI increased UT-A3 protein stability and urea transport activity. Collectively, our study reveals a novel mechanism of UT-A3 regulation by ST6GalI-mediated sialylation modification that may play an important role in kidney urea reabsorption and the urinary concentrating mechanism.

Article

Pasta Supplemented with Opuntia ficus-indica Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study

by Rosaria Vincenza Giglio; Giuseppe Carruba; Arrigo F.G Cicero; Maciej Banach; Angelo Maria Patti; Dragana Nikolic; Letizia Cocciadiferro; Maurizio Zarcone; Yajnavalka Banerjee; Ali A. Rizvi

2020

Subjects
  • Chemistry, Biochemistry
  • Biology, Molecular
  • Health Sciences, Nutrition
  • File Download
  • View Abstract

Abstract:Close

Food supplementation with Opuntia ficus-indica (OFI) has been associated with a significant reduction in total cholesterol, body fat, hyperglycemia and blood pressure. Since OFI may also have antioxidant and anti-atherogenic properties, we hypothesized that its supplementation might reduce atherogenic lipoproteins, including small, dense low-density lipoproteins (sdLDL). Forty-nine patients (13 men and 36 women, mean age: 56 ± 5 years) with one or two criteria for the metabolic syndrome weekly consumed 500 g of pasta supplemented with 3% OFI extract (30% of insoluble polysaccharides with high antioxidant power) for 1 month. The full LDL subclass profile was assessed by gel electrophoresis (Lipoprint, Quantimetrix, Redondo Beach, CA, USA). After 1 month of pasta supplementation, waist circumference (p = 0.0297), plasma glucose (p < 0.0001), triglycerides (p = 0.0137), plasma creatinine (p = 0.0244), urea and aspartate transaminase (p < 0.0001 for each) significantly decreased. A percentage increase in larger, less atherogenic LDL-1 (p = 0.0002), with a concomitant reduction in smaller, denser LDL-2 (p < 0.0001) and LDL-3 (p = 0.0004), were found. LDL-4 and-5 decreased, although not significantly. This is the first intervention study suggesting that pasta enriched with an OFI extract may have beneficial effects on some metabolic parameters and the LDL particle sizes, reducing atherogenic sdLDL. Future studies will help to establish if these findings impact cardiovascular outcomes.

Article

Calcineurin A-beta is required for hypertrophy but not matrix expansion in the diabetic kidney

by Ramesh Reddy; Taylor L Knotts; Brian R Roberts; Jeffery D Molkentin; Stephen Price; Jennifer Gooch

2011

Subjects
  • Health Sciences, Medicine and Surgery
  • Health Sciences, General
  • View Abstract

Abstract:Close

Calcineurin is an important signalling protein that regulates a number of molecular and cellular processes. Previously, we found that inhibition of calcineurin with cyclosporine reduced renal hypertrophy and blocked glomerular matrix expansion in the diabetic kidney. Isoforms of the catalytic subunit of calcineurin are reported to have tissue specific expression and functions. In particular, the β isoform has been implicated in cardiac and skeletal muscle hypertrophy. Therefore, we examined the role of calcineurin β in diabetic renal hypertrophy and glomerular matrix expansion. Type I diabetes was induced in wild-type and β -/- mice and then renal function, extracellular matrix expansion and hypertrophy were evaluated. The absence of β produced a significant decrease in total calcineurin activity in the inner medulla (IM) and reduced nuclear factor of activated T-cells (NFATc) activity. Loss of β did not alter diabetic renal dysfunction assessed by glomerular filtration rate, urine albumin excretion and blood urea nitrogen. Similarly, matrix expansion in the whole kidney and glomerulus was not different between diabetic wild-type and β -/- mice. In contrast, whole kidney and glomerular hypertrophy were significantly reduced in diabetic β -/- mice. Moreover, β -/- renal fibroblasts demonstrated impaired phosphorylation of Erk1/Erk2, c-Jun N-terminal kinases (JNK) and mammalian target of rapamycin (mTOR) following stimulation with transforming growth factor-β and did not undergo hypertrophy with 48 hrs culture in high glucose. In conclusion, loss of the β isoform of calcineurin is sufficient to reproduce beneficial aspects of cyclosporine on diabetic renal hypertrophy but not matrix expansion. Therefore, while multiple signals appear to regulate matrix, calcineurin β appears to be a central mechanism involved in organ hypertrophy. © 2011 The Authors Journal of Cellular and Molecular Medicine © 2011 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd.

Article

In Vivo Detection of Lateral-Ventral Tier Nigral Degeneration in Parkinson's Disease

by Daniel E. Huddleston; Jason Langley; Jan Sedlacik; Kai Boelmans; Stewart Factor; Xiaoping P Hu

2017

Subjects
  • Biology, Neuroscience
  • Engineering, Biomedical
  • Health Sciences, Radiology
  • File Download
  • View Abstract

Abstract:Close

The objective of this study was to measure neuromelanin-sensitive MRI contrast changes in the lateral-ventral tier of substantia nigra pars compacta in Parkinson's disease (PD). Histopathological studies of PD have demonstrated both massive loss of melanized dopamine neurons and iron accumulation in the substantia nigra pars compacta. Neurodegeneration is most profound in the lateral-ventral tier of this structure. We have previously shown in both healthy controls and individuals with PD that neuromelanin-sensitive MRI and iron-sensitive MRI contrast regions in substantia nigra overlap. This overlap region is located in the lateral-ventral tier. Exploiting this area of contrast overlap for region of interest selection, we developed a semi-automated image processing approach to characterize the lateral-ventral tier in MRI data. Here we apply this approach to measure magnetization transfer contrast, which corresponds to local neuromelanin density, in both the lateral-ventral tier and the entire pars compacta in 22 PD patients and 19 controls. Significant co ntrast reductions were seen in PD in both the entire pars compacta (P = 0.009) and in its lateral-ventral tier (P = 0.0002); in PD contrast was significantly lower in the lateral-ventral tier than in the entire pars compacta (P = 0.0008). These findings are the first in vivo evidence of the selective vulnerability of this nigral subregion in PD, and this approach may be developed for high impact biomarker applications. Hum Brain Mapp 38:2627–2634, 2017. © 2017 Wiley Periodicals, Inc.
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
>
Site Statistics
  • 33,723
  • Total Works
  • 7,957,207
  • Downloads
  • 574,146
  • Downloads This Year

Copyright © 2016 Emory University - All Rights Reserved
540 Asbury Circle, Atlanta, GA 30322-2870
(404) 727-6861
Privacy Policy | Terms & Conditions

v2.2.8-dev

Contact Us
Download now